Author/Creator: Irving, P M - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Irving, P M

31. PWE-032 Audit of prevention of opportunistic infections in immunosuppressed patients with inflammatory bowel disease: how close are we to the European Crohn's and Colitis Organisation guidelines?. (23rd September 2015)

Authors:: Elliott, T; Duncan, J; Patel, P; Smith, M; Sanderson, J; Irving, P M
Journal:: Gut
Issue:: Volume 59(2010)Supplement 1
Page Start:: A97
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

32. PWE-067 MRI to distinguish hidradenitis suppurativa from perianal Crohn's disease. (28th May 2012)

Authors:: Griffin, N; Taylor, K M; Williams, A B; Anderson, S H; Irving, P M; Sanderson, J D; Desai, N; Goh, V
Journal:: Gut
Issue:: Volume 61(2012)Supplement 2
Page Start:: A324
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

33. PWE-081 Thioguanine Remains an Acceptable Alternative Immunosuppressant in IBD. (4th June 2013)

Authors:: Patel, K V; Goel, R M; Kariyawasam, V C; Blaker, P A; Ward, M G; Mashari, S; Clark, A; Sastrillo, M; Duncan, J; Anderson, S H; Irving, P M; Sanderson, J D
Journal:: Gut
Issue:: Volume 62(2013)Supplement 1
Page Start:: A163
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

34. PWE-093 Screening with Holotranscobalamin is Superior to Serum B12 in Identifying Vitamin B12 Deficiency in Patients with Crohn'S Disease. (4th June 2013)

Authors:: Ward, M G; Kariyawasam, V C; Blaker, P A; Patel, K V; Goel, R M; Sobczynska-Malefora, A; Ajaegbu, A; Harrington, D J; Anderson, S H; Sanderson, J D; Irving, P M
Journal:: Gut
Issue:: Volume 62(2013)Supplement 1
Page Start:: A168
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

35. PWE-243 Reassessment of Crohn's disease treated with 12 months of anti-TNF therapy: a tertiary centre experience. (28th May 2012)

Authors:: Dart, R; Griffin, N; Taylor, K; Duncan, J; Sastrillo, M; Anderson, S; Sanderson, J; Irving, P M
Journal:: Gut
Issue:: Volume 61(2012)Supplement 2
Page Start:: A397
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

36. Reassessment of Crohn's disease treated with at least 12 months of anti-TNF therapy: how likely is treatment withdrawal?. Issue 3 (24th December 2013)

Authors:: Dart, R J; Griffin, N; Taylor, K; Duncan, J; Sastrillo, M; Sanderson, J; Irving, P M
Journal:: Frontline gastroenterology
Issue:: Volume 5:Issue 3(2014)
Page Start:: 176
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

37. Utilisation of anti-TNF levels in a UK tertiary IBD centre. Issue 3 (29th November 2016)

Authors:: Johnston, E L; Warner, B D; Digby-Bell, J L; Unsworth, N; Anderson, S; Sanderson, J D; Arkir, Z; Irving, P M
Journal:: Frontline gastroenterology
Issue:: Volume 8:Issue 3(2017)
Page Start:: 189
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗